Search

for
Search:

Sort by

Research

360-390 / 1000+ results

Efficacy and Safety of Topical Corticosteroid Treatment Under Occlusion for Severe Alopecia Areata in Children: A Single-Center Retrospective Analysis

research Efficacy and Safety of Topical Corticosteroid Treatment under Occlusion for Severe Alopecia Areata in Children. A single-center retrospective analysis

March 2024 in “Clinical and experimental dermatology”

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

research Skin image analysis for detection and quantitative assessment of dermatitis, vitiligo and alopecia areata lesions: a systematic literature review

5 citations , January 2025 in “BMC Medical Informatics and Decision Making”

Computer vision techniques can help detect and assess skin conditions like vitiligo, alopecia areata, and dermatitis.

research Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie

February 2025 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft”

Deucravacitinib helped a man regrow hair and improve psoriasis.

research Is the severity of alopecia areata associated with arterial stiffness?

5 citations , November 2023 in “Journal of Research in Medical Sciences”

Severe alopecia areata may increase the risk of heart-related diseases.

research Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea

1 citations , January 2025 in “Annals of Dermatology”

Baricitinib is effective and safe for treating alopecia areata in Korea.

research Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib

October 2025 in “Journal of Clinical Medicine”

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Intralesional Methotrexate in Patchy Alopecia Areata: Trichoscopic Evaluation and Effect on Lesional Tumor Necrosis Factor Alpha

research Intralesional methotrexate in patchy alopecia areata: trichoscopic evaluation and effect on lesional tumour necrosis factor alpha

May 2026 in “Journal of the Egyptian Womenʼs Dermatologic Society”

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

research Ayurvedic Management of Indralupta with special reference to Alopecia Areata: A Case Report

June 2025 in “International Journal of AYUSH Case Reports”

Ayurvedic treatment successfully regrew hair in a woman with alopecia areata.

research Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children

January 2024 in “Dermatologic Therapy”

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

research Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)

63 citations , July 2024 in “Journal of the American Academy of Dermatology”

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

research British Association of Dermatologists living guideline for managing people with alopecia areata 2024

20 citations , October 2024 in “British Journal of Dermatology”

The guideline provides recommendations for managing alopecia areata effectively.

research Apremilast for extensive and treatment-resistant alopecia areata: a retrospective analysis of five patients

13 citations , April 2020 in “European Journal of Dermatology”

Apremilast showed mixed results for treating severe alopecia areata.

research Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis

7 citations , September 2024 in “The Journal of Dermatology”

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

research The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study

5 citations , April 2025 in “Journal of Cosmetic Dermatology”

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

research A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata

4 citations , July 2024 in “Pharmacology Research & Perspectives”

Ritlecitinib is safe and may effectively treat alopecia areata.

research Could red and near-infrared emitting fabric technology improve the severity of psoriasis, polymorphous light eruption, and alopecia areata?

4 citations , September 2023 in “Journal of Dermatological Treatment”

Red and near-infrared light-emitting fabric may help improve psoriasis, PMLE, and alopecia areata.

research Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study

1 citations , March 2026 in “American Journal of Clinical Dermatology”

In a 24-week multicentre study in Italy, ritlecitinib 50 mg/day was tested on 102 patients aged 12 and older with severe alopecia areata. The study found that 40.2% of patients experienced significant hair regrowth, with adolescents responding better (48.6%) than adults (21.9%). The mean Severity of Alopecia Tool (SALT) score improved from 86.2 to 40.8, and improvements were noted in trichoscopic signs, quality of life, and hair regrowth on eyebrows, eyelashes, and nails. The treatment was generally well tolerated, with mild adverse events like acne and headache, and only one severe case of anaemia. Overall, ritlecitinib was effective and safe, particularly for adolescents.

research A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle

1 citations , September 2025 in “Frontiers in Immunology”

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

research COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA

1 citations , April 2025

Baricitinib works better than methotrexate for severe alopecia areata.

research Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience

March 2026 in “Immunological Medicine”

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

research Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata

February 2026 in “The Journal of Dermatology”

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

research Real-World Effectiveness of JAK Inhibitors for Alopecia Totalis and Alopecia Universalis: A Single-Center Experience

November 2025 in “Journal of Cutaneous Medicine and Surgery”

JAK inhibitors are effective and safe for treating severe alopecia areata.

Comparative Study of Two Concentrations (2.5 mg/mL and 5 mg/mL) of Intralesional Triamcinolone Acetonide in the Treatment of Alopecia Areata

research COMPARATIVE STUDY OF TWO CONCENTRATIONS (2.5MG/ML AND 5 MG/ML) OF INTRALESIONAL TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF ALOPECIA AREATA

September 2025 in “Tạp chí Da liễu học Việt Nam”

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

research Interleukin 15 Gene Polymorphism in patients with Alopecia Areata

July 2022 in “The Egyptian Journal of Hospital Medicine”

Targeting IL-15 may help treat Alopecia Areata.

research Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA

November 2024 in “SKIN The Journal of Cutaneous Medicine”

Disease-specific tools better assess quality of life in alopecia areata patients.

Patient-Reported Outcomes for Scalp, Eyebrow, and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from Two Phase 3 Clinical Trials

research 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials

September 2024 in “Journal of the American Academy of Dermatology”

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

research FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata

3 citations , November 2024 in “Clinical Research”

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

research Refractory alopecia areata with single hairs imitating frontal fibrosing alopecia: a prospective observational study

2 citations , December 2023 in “International Journal of Dermatology”

A unique type of hair loss mimics another condition but has minimal inflammation and specific immune cells present.

research Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata

1 citations , December 2025 in “Photodermatology Photoimmunology & Photomedicine”

Phototherapy effectively treats certain alopecia areata types, especially if started early.

research Nemolizumab Treatment for Severe Atopic Dermatitis Led to the Simultaneous Improvement of Coexisting Refractory Alopecia Areata: A Case Report

November 2025 in “The Journal of Dermatology”

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

← Previous page Next page →